Fundies. English
Segment disclosures
Company overviewCENTENE CORPORATION
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
78 dimension combinations 776 retained observations 16 reported periods Partial retained history
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Intersegment Elimination · Commercial Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Intersegment Elimination · Medicaid Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Intersegment Elimination · Medicare Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Intersegment Elimination · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | -4099000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | -8245000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | -4146000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | -16854000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -4194000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -12325000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | -3967000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | -8131000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | -4164000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -16879000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -4290000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | -12451000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -4081000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -8161000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | -4080000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -16735000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -3978000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -11634000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | -3789000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | -7656000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | -3867000000 | USD | 20240426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -25191000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Total Premium And Service · Commercial Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 9556000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 42003000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10992000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31211000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10070000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20219000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10149000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 33702000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8693000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 24979000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8535000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16286000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7751000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 24845000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6453000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17439000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 17380000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Total Premium And Service · Medicaid Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 23596000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 90238000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 23171000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 67193000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 21723000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 44022000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 22299000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 83851000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 21316000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 63026000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 20250000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41710000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 21460000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 86855000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 21619000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 65741000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 84083000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Total Premium And Service · Medicare Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 10326000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 37210000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9391000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27600000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9450000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18209000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8759000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 23032000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5643000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17556000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5978000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11913000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5935000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22261000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5430000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16971000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 22484000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Total Premium And Service · All Other Segments
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1177000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 5130000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1344000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3850000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1224000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2506000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1282000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4920000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1247000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3648000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1210000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2401000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1191000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1465000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4606000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 11532000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Health Care Premium · Commercial Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 9555000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 42001000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10991000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31209000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10070000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20218000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10148000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 33699000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8693000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 24977000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8534000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16284000000 | USD | 20250725 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 24843000000 | USD | 20260217 | Open filing evidence |
Operating Segments · Health Care Premium · Medicaid Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 23573000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 90137000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 23146000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 67118000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 21697000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 43972000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 22275000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 83758000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 21291000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 62958000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 20229000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41667000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 21438000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 86853000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 21619000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 65741000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 84084000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Health Care Premium · Medicare Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 10326000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 37210000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9391000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27600000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9450000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18209000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8759000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 23032000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5643000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17556000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5978000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11913000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5935000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22261000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5430000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16971000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 22484000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Health Care Premium · All Other Segments
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 433000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2208000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 598000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1651000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 523000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1053000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 530000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1814000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 488000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1293000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 399000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 805000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 406000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1679000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 366000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1255000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 470000000 | USD | 20240426 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3186000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Service · Commercial Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Service · Medicaid Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 23000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 101000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 25000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 75000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 26000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 50000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 24000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 93000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 25000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 68000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 43000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 22000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | -1000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Service · Medicare Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Operating Segments · Service · All Other Segments
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 744000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2922000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 746000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2199000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 701000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1453000000 | USD | 20250725 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 752000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3106000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 759000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2355000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 811000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1596000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 785000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4455000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1099000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3351000000 | USD | 20241025 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 8346000000 | USD | 20250218 | Open filing evidence |
Operating Segments · Commercial Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Operating Segments · Managed Care
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:ManagedCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 135055000000 | USD | 20230221 | Open filing evidence |
Operating Segments · Medicaid Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Operating Segments · Medicaid Segment · Health Care Premium
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 22227000000 | USD | 20230425 | Open filing evidence |
Operating Segments · Medicare Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250218 | Open filing evidence |
Operating Segments · Medicare Segment · Service
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
Operating Segments · Specialty Services
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:SpecialtyServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 9492000000 | USD | 20230221 | Open filing evidence |
Operating Segments · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 4099000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 8245000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4146000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 16854000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4194000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 12325000000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3967000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8131000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4164000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 16879000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 4290000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 12451000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4081000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8161000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4080000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 16735000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3978000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11634000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 3867000000 | USD | 20240426 | Open filing evidence |
Total Premium And Service · Operating Segments · Commercial Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 8535000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16286000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 24845000000 | USD | 20240220 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5734000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10986000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5252000000 | USD | 20230425 | Open filing evidence |
Total Premium And Service · Operating Segments · Medicaid Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 20250000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41710000000 | USD | 20240726 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 21619000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 65741000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21895000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 44122000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 22227000000 | USD | 20230425 | Open filing evidence |
Total Premium And Service · Operating Segments · Medicare Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 5665000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11541000000 | USD | 20230728 | Open filing evidence |
Total Premium And Service · Operating Segments · All Other Segments
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 1191000000 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1597000000 | USD | 20240426 | Open filing evidence |
Total Premium And Service · Commercial Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9356000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 18912000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10070000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20219000000 | USD | 20260728 | Open filing evidence |
Total Premium And Service · Medicaid Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 22766000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 46362000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 21723000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 44022000000 | USD | 20260728 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 21460000000 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 22227000000 | USD | 20240426 | Open filing evidence |
Total Premium And Service · Medicare Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 11057000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21383000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9450000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18209000000 | USD | 20260728 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5935000000 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5430000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16971000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5876000000 | USD | 20240426 | Open filing evidence |
Total Premium And Service · All Other Segments · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1196000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2373000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1224000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2506000000 | USD | 20260728 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1465000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4606000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1544000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3141000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1597000000 | USD | 20230425 | Open filing evidence |
Health Care Premium · Operating Segments · Medicaid Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 20229000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 41667000000 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21895000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 44122000000 | USD | 20240726 | Open filing evidence |
Health Care Premium · Operating Segments · Medicare Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 5665000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11541000000 | USD | 20230728 | Open filing evidence |
Health Care Premium · Commercial Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 10148000000 | USD | 20250425 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 33699000000 | USD | 20250218 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8693000000 | USD | 20241025 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 24977000000 | USD | 20241025 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8534000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16284000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7750000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 24843000000 | USD | 20250218 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6451000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17437000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5734000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10986000000 | USD | 20240726 | Open filing evidence |
Health Care Premium · Commercial Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9355000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 18910000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10070000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20218000000 | USD | 20260728 | Open filing evidence |
Health Care Premium · Medicaid Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 22745000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 46318000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 21697000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 43972000000 | USD | 20260728 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21895000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 44122000000 | USD | 20230728 | Open filing evidence |
Health Care Premium · Medicare Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 11057000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21383000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9450000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18209000000 | USD | 20260728 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5978000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11913000000 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5665000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11541000000 | USD | 20240726 | Open filing evidence |
Health Care Premium · All Other Segments · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 425000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 858000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 523000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1053000000 | USD | 20260728 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1679000000 | USD | 20240220 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 419000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 889000000 | USD | 20230728 | Open filing evidence |
Service · Operating Segments · Commercial Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 2000000 | USD | 20240220 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
Service · Operating Segments · Medicaid Segment
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
Service · Operating Segments · All Other Segments
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 785000000 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1127000000 | USD | 20240426 | Open filing evidence |
Service · Commercial Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1000000 | USD | 20260728 | Open filing evidence |
Service · Medicaid Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 21000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 44000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 26000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 50000000 | USD | 20260728 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 22000000 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Service · Medicare Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260728 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Service · All Other Segments · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 771000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1515000000 | USD | 20260728 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 701000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1453000000 | USD | 20260728 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4455000000 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1099000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3351000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1127000000 | USD | 20230425 | Open filing evidence |
Commercial Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 8700000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 27612000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 9356000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 18912000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 9556000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 42003000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10992000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31211000000 | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10070000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20219000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10149000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 33702000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8693000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 24979000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8535000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16286000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7751000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 24845000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6453000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17439000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5734000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10986000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5252000000 | USD | 20240426 | Open filing evidence |
Commercial Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Commercial Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Commercial Segment · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
Commercial Segment · Total Premium And Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 8700000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 27612000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10992000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31211000000 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7751000000 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6453000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17439000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5734000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10986000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5252000000 | USD | 20240426 | Open filing evidence |
Commercial Segment · Health Care Premium
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 7750000000 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6451000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17437000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5734000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 10986000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5252000000 | USD | 20240426 | Open filing evidence |
Commercial Segment · Health Care Premium · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 8699000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 27609000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10991000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 31209000000 | USD | 20261027 | Open filing evidence |
Commercial Segment · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:CommercialSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 3000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2000000 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1000000 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Medicaid Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 29581000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 90436000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 31970000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 60855000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 28885000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 110434000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 27963000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 82391000000 | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 27998000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 54428000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 26430000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 101417000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26440000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 76083000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 24113000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 49643000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 25530000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 100759000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 24694000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 75523000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 24665000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 50829000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 26164000000 | USD | 20240426 | Open filing evidence |
Medicaid Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240220 | Open filing evidence |
Medicaid Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240220 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Medicaid Segment · Operating Segments · Health Care Premium
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 21438000000 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 22227000000 | USD | 20240426 | Open filing evidence |
Medicaid Segment · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230728 | Open filing evidence |
Medicaid Segment · Total Premium And Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 24039000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 70401000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 23171000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 67193000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 86855000000 | USD | 20240220 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 21895000000 | USD | 20230728 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 44122000000 | USD | 20230728 | Open filing evidence |
Medicaid Segment · Health Care Premium · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 24004000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 70322000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 23146000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 67118000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 86853000000 | USD | 20240220 | Open filing evidence |
Medicaid Segment · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicaidSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 35000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 79000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 25000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 75000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2000000 | USD | 20240220 | Open filing evidence |
Medicare Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 11263000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 32646000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 11057000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21383000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 10326000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 37210000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9391000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27600000000 | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9450000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18209000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8759000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 23032000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5643000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17556000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5978000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11913000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5935000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22261000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5430000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16971000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5665000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11541000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5876000000 | USD | 20240426 | Open filing evidence |
Medicare Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
Medicare Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240426 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240426 | Open filing evidence |
Medicare Segment · Operating Segments · Health Care Premium
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 5935000000 | USD | 20240426 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5430000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 16971000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5876000000 | USD | 20240426 | Open filing evidence |
Medicare Segment · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240726 | Open filing evidence |
Medicare Segment · Total Premium And Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 11263000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 32646000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9391000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27600000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5978000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11913000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22261000000 | USD | 20240220 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5665000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11541000000 | USD | 20240726 | Open filing evidence |
Medicare Segment · Health Care Premium · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 11263000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 32646000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9391000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27600000000 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22261000000 | USD | 20240220 | Open filing evidence |
Medicare Segment · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cnc:MedicareSegmentMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261027 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240220 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230425 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1103000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 3476000000 | USD | 20261027 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 1196000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2373000000 | USD | 20260728 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1177000000 | USD | 20260428 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 5130000000 | USD | 20260217 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1344000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3850000000 | USD | 20261027 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1224000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2506000000 | USD | 20260728 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1282000000 | USD | 20260428 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 4920000000 | USD | 20260217 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1247000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3648000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1210000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2401000000 | USD | 20250725 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1191000000 | USD | 20250425 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6134000000 | USD | 20260217 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1465000000 | USD | 20241025 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4606000000 | USD | 20241025 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1544000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3141000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1597000000 | USD | 20240426 | Open filing evidence |
All Other Segments · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | -3749000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | -11994000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | -4194000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | -12325000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | -4081000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | -8161000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -16735000000 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | -3978000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | -11634000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | -3789000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | -7656000000 | USD | 20240726 | Open filing evidence |
All Other Segments · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 3749000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 11994000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4194000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 12325000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4081000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8161000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 16735000000 | USD | 20240220 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3978000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11634000000 | USD | 20231024 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3789000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 7656000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 3867000000 | USD | 20230425 | Open filing evidence |
All Other Segments · Operating Segments · Health Care Premium
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 366000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1255000000 | USD | 20231024 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 470000000 | USD | 20230425 | Open filing evidence |
All Other Segments · Operating Segments · Service
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 811000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1596000000 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1125000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 2252000000 | USD | 20240726 | Open filing evidence |
All Other Segments · Total Premium And Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ProductOrServiceAxis=cnc:TotalPremiumAndServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1103000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 3476000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1344000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3850000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1210000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2401000000 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1544000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3141000000 | USD | 20240726 | Open filing evidence |
All Other Segments · Health Care Premium · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ProductOrServiceAxis=us-gaap:HealthCarePremiumMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 404000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 1262000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 598000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1651000000 | USD | 20261027 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 399000000 | USD | 20240726 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 805000000 | USD | 20240726 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 419000000 | USD | 20240726 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 889000000 | USD | 20240726 | Open filing evidence |
All Other Segments · Service · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 699000000 | USD | 20261027 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2214000000 | USD | 20261027 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 746000000 | USD | 20261027 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2199000000 | USD | 20261027 | Open filing evidence |